Short answer
MEDIFAST INC (MED) filed its Q2 2026 10-Q quarterly report on Aug 3, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $76M (down 27.6% year over year) with net income of −$3M.
Q2 2026 key financials · XBRL
- Revenue
- $76M
- −27.6% YoY · +0.4% QoQ
- Net income
- −$3M
- −225.0% YoY · −46.1% QoQ
- Operating margin
- -5.7%
- Gross margin
- 69.9%
- EPS (diluted)
- −$0.28
- −227.3% YoY · −47.4% QoQ
Source: XBRL data from the MEDIFAST INC (MED) Q2 2026 10-Q on SEC EDGAR. USD.
MEDIFAST INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $76.4M, down 27.6% YoY from $105.6M, driven by active earning coaches falling to 11,700 from 22,800
- Gross margin 69.9% vs 72.6% YoY; operating margin (5.7%) vs (1.0%)
- Average revenue per active coach $6,529, up 41.0% from $4,630
- Active earning coaches expected to continue declining in 2026 amid GLP-1 adoption and client-acquisition pressure
- Trilivy Reset Fueling line launched; updated product line expected fully marketed this quarter
Risk Factors
- No Risk Factors section provided; supplied text covers equity repurchases, trading arrangements, and exhibits
- Repurchase-plan risk: 1,323,568 shares remained eligible, with timing and pricing dependent on market conditions
- Insider-trading disclosure: Chairman Daniel R. Chard adopted a Rule 10b5-1 arrangement for up to 19,089 shares
- Governance flexibility: Board may modify or terminate the Stock Repurchase Plan at any time
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MEDIFAST INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.